The purpose of this study is to evaluate the complete response (CR) rate after Intensified
1st cycle Rituximab plus 3rd cycles of R-CHOP in DLBCL
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01054781
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
All locations for NCT01054781
Korea, Republic of (1)
Samsung Medical Center
Seoul, Korea, Republic of
View full eligibility
Tris trial is registered with FDA with number: NCT01054781. The sponsor of the trial is Samsung Medical Center and it is looking for 91 volunteers for the current phase.
Official trial title: Open-labelled, Multicenter Phase II Study of Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.